About Us

We are applying our innovative technology platform to build a leading, fully integrated global pharmaceutical company

We are applying our innovative technology platform to build a leading, fully integrated global pharmaceutical company

Algorithm for product innovation

Our unique approach to product innovation focuses on identifying unmet medical needs where a clinically validated parent drug or pathway is suitable to our TransCon technologies. We call this our “algorithm.” It helps us select and advance product candidates for our ever-growing pipeline.

Leveraging this strategic approach, we currently have a pipeline of independent endocrinology rare disease product candidates in clinical development, and we are advancing oncology as a second therapeutic area of focus. We continue to expand into new therapeutic areas to address unmet patient needs.

About_Us_Algorithm
Vector-Smart-Object-copy

Our vision is to create new therapies focused on making a meaningful difference in patients’ lives.

Explore

You are about to access www.ascendispharma.com. Click below if you wish to proceed.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s global website, which is not intended for a UK audience.

You are leaving the UK website to go to Ascendis Pharma’s investors and news website, which is not intended for a UK audience